Literature DB >> 14991952

Detection of K-ras gene mutation in fecal samples from elderly large intestinal cancer patients and its diagnostic significance.

Jun Wan1, Zi-Qi Zhang, Wei-Di You, Hua-Kui Sun, Jian-Ping Zhang, Ya-Hong Wang, Yong-He Fu.   

Abstract

AIM: To study the diagnostic significance of K-ras gene mutations in fecal samples from elderly patients with large intestinal cancer.
METHODS: DNA was extracted in the fecal and tissue samples from 23 large intestinal cancer patients, 20 colonic adenomatoid polypus patients and 20 healthy subjects. The K-ras gene mutations at the first and second bases of codon 12 were detected by the allele specific mismatch method.
RESULTS: The K-ras gene mutation was 56.52%(13/23) in the large intestinal cancer patients, which was notably higher than that in the normal subjects whose K-ras gene mutation was 5%(1/20) (chi (2)=12.93, P<0.001). There was no significant difference in comparison with that of colonic adenomatoid polypus patients whose K-ras gene mutation was 30%(6/12) (chi (2)=3.05, P>0.05). The K-ras gene mutation at the second base of codon 12 was 92.13%(12/13) in the large intestinal cancer patients. There was no significant difference between the detection rate of K-ras gene mutation in the fecal and tissue samples (chi (2)=9.35, P<0.01).
CONCLUSION: Our results indicate that detection of the K-ras gene mutations in fecal samples provides a non-invasive diagnostic method for the elderly large intestinal cancer patients. Its significance in the early diagnosis of large intestinal cancer awaits further studies.

Entities:  

Mesh:

Year:  2004        PMID: 14991952      PMCID: PMC4716923          DOI: 10.3748/wjg.v10.i5.743

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  K-ras mutations and RASSF1A promoter methylation in colorectal cancer.

Authors:  Manon van Engeland; Guido M J M Roemen; Mirian Brink; Marco M M Pachen; Matty P Weijenberg; Adriaan P de Bruïne; Jan-Willem Arends; Piet A van den Brandt; Anton F P M de Goeij; James G Herman
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

3.  Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas.

Authors:  A Rashid; M Zahurak; S N Goodman; S R Hamilton
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

4.  Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.

Authors:  Yasushi Ito; Susumu Kobayashi; Tetsushi Taniguchi; Osamu Kainuma; Tsuyosi Hara; Takenori Ochiai
Journal:  Int J Oncol       Date:  2002-06       Impact factor: 5.650

5.  Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces.

Authors:  C Ratto; G Flamini; L Sofo; P Nucera; M Ippoliti; G Curigliano; G Ferretti; A Sgambato; M Merico; G B Doglietto; A Cittadini; F Crucitti
Journal:  Dis Colon Rectum       Date:  1996-11       Impact factor: 4.585

6.  Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients.

Authors:  J Smith-Ravin; J England; I C Talbot; W Bodmer
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

Review 7.  Colorectal cancer: future population screening for early colorectal cancer.

Authors:  H E Blum
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

Review 8.  Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

9.  Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability.

Authors:  Mario Hermsen; Cindy Postma; Jan Baak; Marjan Weiss; Anna Rapallo; Andrea Sciutto; Guido Roemen; Jan-Willem Arends; Richard Williams; Walter Giaretti; Anton De Goeij; Gerrit Meijer
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

10.  p53 expression and K-ras mutation in colorectal adenomas.

Authors:  N Scott; S M Bell; P Sagar; G E Blair; M F Dixon; P Quirke
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

View more
  4 in total

1.  Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran.

Authors:  Mohammad Reza Abbaszadegan; Alireza Tavasoli; Arash Velayati; Hamid Reza Sima; Hassan Vosooghinia; Mehdi Farzadnia; Hamid Asadzedeh; Mehran Gholamin; Ezzat Dadkhah; Azadeh Aarabi
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

2.  Loss of heterozygosity of Kras2 gene on 12p12-13 in Chinese colon carcinoma patients.

Authors:  Jun Wan; Hong Li; Yuan Li; Mei-Ling Zhu; Po Zhao
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

3.  Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells.

Authors:  Rebecca S Henkhaus; Eugene W Gerner; Natalia A Ignatenko
Journal:  Biol Chem       Date:  2008-06       Impact factor: 3.915

Review 4.  The Diagnostic Performance of Stool DNA Testing for Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Rong-Lin Zhai; Fei Xu; Pei Zhang; Wan-Li Zhang; Hui Wang; Ji-Liang Wang; Kai-Lin Cai; Yue-Ping Long; Xiao-Ming Lu; Kai-Xiong Tao; Guo-Bin Wang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.